Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma.
Ruffini PA
Curr Gene Ther. 5(5):511-21.
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.
Siena S
J Clin Oncol. 18(6):1360-77.
Cell therapy: achievements and perspectives.
Bordignon C
Haematologica. 84(12):1110-49.
Ex vivo expansion of hematopoietic cells and their clinical use.
Aglietta M
Haematologica. 83(9):824-48.
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging.
Rizzoli V, Carlo-Stella C
Crit Rev Oncol Hematol. 26(2):101-15.
Stem cells and stem cell transplantation.
Carlo-Stella C, Tabilio A
Haematologica. 81(6):573-87.
Stem cell purging: an intriguing dilemma.
Rizzoli V, Carlo-Stella C
Exp Hematol. 23(4):296-302.
Counterflow centrifugal elutriation: present and future.
Almici C
Bone Marrow Transplant. 12(2):105-8.
Autologous bone marrow transplantation in acute myelogenous leukemia.
Rizzoli V, Mangoni L, Carlo-Stella C
Leukemia. 6(11):1101-6.
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients.
Pouillon L
Aliment Pharmacol Ther. 2019 Apr 1;49(9):1181-1187. doi: 10.1111/apt.15223